NCT02472015

Brief Summary

Telemedicine may facilitate adequate treatment of Neuropsychiatric symptoms (NPS) by identifying underlying causes and tailoring a treatment plan (pharmacological or non-pharmacologic treatments including provision of staff education and support, training in problem solving, and targeted therapy directed at the underlying causes for specific behaviors).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
143

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2015

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 15, 2015

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

June 1, 2023

Status Verified

May 1, 2023

Enrollment Period

2.4 years

First QC Date

June 1, 2015

Last Update Submit

May 31, 2023

Conditions

Dementia

Keywords

neuropsychiatric symptomsdementiatelemedicinelong-term care facilities

Outcome Measures

Primary Outcomes (1)

  • Acceptability of the TM among the LTCF staff

    Acceptability of the telemedicine (TM) among the LTCF staff which will be assessed in the intervention group by quantitative indicators (proportion of the solicitation of the TM solution among patients with disruptive NPS, the delay to obtain a TM consultation and the number of the staff participants at each TM consultation) and qualitative indicators (staff global satisfaction will be evaluated by focus groups and interviewing).

    6 months

Secondary Outcomes (4)

  • Rate of non-programmed hospitalizations and/or consultation due to disruptive NPS

    6 months

  • The psychotropic drugs used

    6 months

  • describe the health costs

    6 months

  • describe the estimation of the cluster effect ("design effect")

    6 months

Study Arms (2)

normal care

NO INTERVENTION

patients who will have normal care

telemedicine

EXPERIMENTAL

patients who will have telemedicine

Procedure: telemedicine

Interventions

telemedicinePROCEDURE

psycho-behavioural care by telemedicine

telemedicine

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • patient aged 65 or more, with a dementia diagnosed by a specialist or the general practitioner;
  • patient presenting with a disruptive NPS as defined in French Haute Autorité de Santé (HAS) recommendations (2009), that requires a specialist consultation based on the LTCF staff judgment;
  • informed and written consent by the patient or the legal representative or the reliable person when appropriate;
  • general practitioner agreement.

You may not qualify if:

  • patient's life expectancy less than 6 months;
  • Non agreement of study participation of patients or legal representative or the reliable person when appropriate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UHLimoges

Limoges, 87042, France

Location

UHToulouse

Toulouse, 31300, France

Location

Related Publications (2)

  • Piau A, Nourhashemi F, De Mauleon A, Tchalla A, Vautier C, Vellas B, Duboue M, Costa N, Rumeau P, Lepage B, Soto Martin M. Telemedicine for the management of neuropsychiatric symptoms in long-term care facilities: the DETECT study, methods of a cluster randomised controlled trial to assess feasibility. BMJ Open. 2018 Jun 12;8(6):e020982. doi: 10.1136/bmjopen-2017-020982.

    PMID: 29895651BACKGROUND

  • Piau A, Vautier C, De Mauleon A, Tchalla A, Rumeau P, Nourhashemi F, Soto-Martin M. Health workers perception on telemedicine in management of neuropsychiatric symptoms in long-term care facilities: Two years follow-up. Geriatr Nurs. 2020 Nov-Dec;41(6):1000-1005. doi: 10.1016/j.gerinurse.2020.07.009. Epub 2020 Aug 6.

    PMID: 32771311RESULT

MeSH Terms

Conditions

Dementia

Interventions

Telemedicine

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Maria Soto, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 1, 2015

First Posted

June 15, 2015

Study Start

June 1, 2015

Primary Completion

November 1, 2017

Study Completion

November 1, 2017

Last Updated

June 1, 2023

Record last verified: 2023-05

Locations

FR(2)